BSE filing, NSE: OMKARPH. Summary written from the filing by ALFA Finder's alert engine.
Omkar Pharmachem Ltd: key numbers
- Share price
- ₹6.57
- Market cap
- ₹6.63 Cr
- Revenue (annual)
- ₹0.46 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 77.8×Sector 34.1×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omkar Pharmachem Ltd
All →Omkar Pharmachem Other Announcement
Omkar Pharmachem Ltd filed its quarterly shareholding pattern and provided an explanation regarding missing PAN details for certain public shareholders.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Limited concluded its 31st Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and approval of material related party transactions.
Omkar Pharmachem Annual Report
Omkar Pharmachem Ltd has submitted its 31st Annual Report and Notice for the Annual General Meeting scheduled for September 30, 2026. The agenda includes approving audited accounts.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Ltd has scheduled its 31st Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and approving material related party transactions.
- Execution
- FY 2026-27
Omkar Pharmachem Q1 FY27 Results: Net Profit ₹0 Cr
Omkar Pharmachem Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Omkar Pharmachem Board Meeting Date
Omkar Pharmachem will hold a board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.